细胞膜胆固醇由于转运物质寡合化变化而影响着血清素转运物质流出
Deborah Rudin1, Dino Luethi1,2, Marco Niello1,3
1Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Waehringer Strasse 13A, 1090, Vienna, Austria.
Molecular psychiatry
|September 2, 2025
概括
降低胆固醇会影响单胺转运体 (MAT) 功能,降低吸收和结合亲和力. 这影响了输送器构造和SERT寡合化,选择性地增加了通过SERT输出的安非他命.
科学领域:
- 神经科学
- 分子生物学
- 生物化学
背景情况:
- 单胺转运体 (MAT) 通过从突触裂清除神经递质来调节神经递质.
- 包括SERT,DAT和NET在内的MAT嵌入细胞膜,与胆固醇等脂质相互作用.
- 已经确定了胆固醇在MAT功能中的作用,包括形状,亲和力和传输速率,但需要对MAT进行详细的比较.
研究的目的:
- 为了比较胆固醇对血清素 (SERT),多巴胺 (DAT) 和上腺素 (NET) 载体的吸收,排放,结合亲和和和寡合的调节作用.
- 研究胆固醇消耗如何影响转运体构成和基质相互作用.
- 阐明胆固醇影响MAT功能的具体机制,特别是胺诱导的排泄.
主要方法:
- 使用人类转运器转移的HEK293细胞来评估转运器介导的吸收和结合亲和力.
- 在SERT表达细胞中使用电生理记录来分析输送器结构变化.
- 应用Förster共振能量转移 (FRET) 成像和单分子显微镜来研究输送器寡合化.
主要成果:
- 胆固醇消耗导致输送媒介吸收受损,并降低了对所有三种MAT (SERT,DAT,NET) 的结合亲和力.
- 电生理学表明胆固醇变化会影响SERT的形状转变. 在胆固醇耗尽后,FRET和显微镜检测显示了改变的SERT寡合化.
- 降低的膜胆固醇选择性地通过SERT增加了安非他命诱导的排泄量,但对DAT和NET降低了排泄量,这种效应取决于PIP2结合能力.
结论:
- 胆固醇在MAT功能中起着至关重要的调节作用,影响吸收,结合,构成和寡合化.
- 在胆固醇耗尽后观察到的SERT流量增加与PIP2结合有关,这表明一种特定的脂质- 蛋白相互作用.
- 这些发现突显了膜胆固醇和MAT之间的复杂关系,可能会影响MAT依赖性疾病的病理生理学.
相关概念视频
Membrane Asymmetry Regulating Transporters
4.9K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
4.9K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
395
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
395
Membrane Fluidity
155.7K
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
155.7K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
260
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
260
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.4K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.4K


